Sales & Marketing News | pharmaphorum

News

Lower COVID sales weigh on AZ in fourth quarter

Sales of AstraZeneca's COVID-19 vaccine dwindled to almost nothing in the fourth quarter of 2022, contributing to a weaker-than-expected performance for the group.

News

Bill Anderson will replace Baumann as Bayer CEO

Just weeks after Roche pharma chief Bill Anderson resigned to seek other opp

News

Sandoz files biosimilar of Amgen osteoporosis drug in US

Novartis' soon-to-be-divested Sandoz unit has filed its proposed biosimilar of Amgen's osteoporosis therapy Prolia/Xgeva with the FDA, saying it is "among the first" to fi

News

Eisai says early Leqembi rollout exceeds its hopes

Eisai didn't reveal sales of its new Alzheimer's disease therapy Leqembi in its third-quarter update, but said the launch was running "ahead of expectations" since the dru

News

Naoki Okamura named as next CEO of Astellas

Kenji Yasukawa is stepping down as chief executive of Japanese pharma group Astellas, to be succeeded by Naoki Okamura – currently chief strategy officer – on 1st April.

News

Gilead buoyed by Trodelvy OK in new breast cancer use

The reversal of fortunes for Gilead Sciences' Trodelvy in an advanced form of breast cancer is complete, with an FDA approval unlocking what could be a sizeable new market

Lower COVID sales weigh on AZ in fourth quarter

Bill Anderson will replace Baumann as Bayer CEO

Sandoz files biosimilar of Amgen osteoporosis drug in US

Eisai says early Leqembi rollout exceeds its hopes

Naoki Okamura named as next CEO of Astellas

Gilead buoyed by Trodelvy OK in new breast cancer use

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks